Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ann Thor

Concepts (434)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
64
2022
1862
4.030
 Why?
Receptor, ErbB-2
24
2018
300
2.790
 Why?
Metformin
10
2018
276
2.270
 Why?
Tamoxifen
10
2020
191
1.570
 Why?
Receptors, Estrogen
15
2020
372
1.490
 Why?
Receptor, ErbB-3
8
2016
41
1.360
 Why?
Cell Proliferation
15
2018
2186
1.220
 Why?
Genes, erbB-2
8
2013
26
1.140
 Why?
Mammary Neoplasms, Experimental
6
2017
64
1.100
 Why?
Apoptosis
20
2018
2362
0.840
 Why?
Cell Line, Tumor
22
2020
2710
0.780
 Why?
Thyroid Hormones
1
2020
53
0.710
 Why?
Up-Regulation
3
2020
807
0.690
 Why?
Hormone Replacement Therapy
1
2020
77
0.680
 Why?
Triple Negative Breast Neoplasms
3
2016
157
0.650
 Why?
Mammary Neoplasms, Animal
3
2018
28
0.630
 Why?
Disease-Free Survival
11
2020
620
0.610
 Why?
Immunohistochemistry
24
2017
1629
0.580
 Why?
Tumor Suppressor Protein p53
13
2011
445
0.580
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1141
0.560
 Why?
Biomarkers, Tumor
10
2021
1040
0.550
 Why?
ErbB Receptors
4
2010
554
0.550
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
62
0.550
 Why?
Testicular Neoplasms
3
2023
96
0.540
 Why?
Antineoplastic Agents
9
2018
1879
0.520
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1355
0.520
 Why?
Claudins
1
2016
24
0.510
 Why?
Receptor, IGF Type 1
3
2016
58
0.500
 Why?
Transcriptome
1
2020
725
0.490
 Why?
Hypoglycemic Agents
3
2017
1008
0.470
 Why?
Prognosis
17
2016
3328
0.470
 Why?
Carcinogenesis
1
2016
177
0.460
 Why?
Carcinoma, Ductal, Breast
5
2002
76
0.450
 Why?
Estradiol
2
2009
455
0.440
 Why?
Cell Cycle
4
2013
542
0.440
 Why?
Trastuzumab
7
2016
89
0.430
 Why?
Caspases
4
2009
245
0.430
 Why?
Lymphatic Metastasis
16
2021
275
0.420
 Why?
Genistein
2
2010
11
0.420
 Why?
Female
64
2022
59466
0.400
 Why?
Antineoplastic Agents, Hormonal
5
2020
138
0.390
 Why?
Receptors, Steroid
1
2012
47
0.390
 Why?
Signal Transduction
15
2018
4509
0.380
 Why?
Antimetabolites, Antineoplastic
1
2012
81
0.380
 Why?
Drug Resistance, Neoplasm
9
2016
636
0.380
 Why?
STAT3 Transcription Factor
1
2012
173
0.350
 Why?
Neoplasm Invasiveness
7
2016
442
0.350
 Why?
Genes, p53
5
2000
61
0.340
 Why?
Humans
81
2023
114623
0.340
 Why?
Neoplasm Proteins
5
2016
384
0.320
 Why?
Glucose
1
2013
896
0.310
 Why?
Glycoproteins
2
2005
304
0.300
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
386
0.300
 Why?
Mice
17
2022
14860
0.300
 Why?
Mammary Tumor Virus, Mouse
2
2004
42
0.290
 Why?
Mice, Transgenic
8
2018
1947
0.290
 Why?
MicroRNAs
4
2021
600
0.280
 Why?
MCF-7 Cells
4
2020
105
0.270
 Why?
Carcinoma
4
1995
198
0.270
 Why?
Protein Kinase Inhibitors
3
2016
785
0.260
 Why?
Doxorubicin
9
2011
285
0.260
 Why?
Bromodeoxyuridine
2
1999
72
0.250
 Why?
Polymerase Chain Reaction
6
2021
993
0.250
 Why?
Xenograft Model Antitumor Assays
3
2020
698
0.240
 Why?
Animals
22
2022
31694
0.240
 Why?
Antibodies, Monoclonal
6
2013
1262
0.240
 Why?
Tyrosine
2
2007
214
0.230
 Why?
Radiation Tolerance
1
2005
92
0.230
 Why?
Quinazolines
2
2016
240
0.230
 Why?
Phosphorylation
5
2011
1569
0.220
 Why?
Cocarcinogenesis
1
2003
14
0.220
 Why?
Cell Survival
5
2018
1020
0.220
 Why?
Isoflavones
1
2003
16
0.220
 Why?
Paclitaxel
4
2015
190
0.220
 Why?
Seminoma
1
2023
17
0.210
 Why?
Multivariate Analysis
7
2005
1430
0.210
 Why?
Receptors, Progesterone
5
2012
319
0.210
 Why?
Chromosomes
1
2003
85
0.210
 Why?
Chromosomes, Human, Pair 8
1
2002
33
0.200
 Why?
Cyclins
2
2000
78
0.200
 Why?
Chromosome Aberrations
1
2002
135
0.190
 Why?
Enzyme Activation
3
2009
785
0.190
 Why?
Obesity
4
2022
2507
0.190
 Why?
Ki-67 Antigen
3
2014
103
0.190
 Why?
Diet
3
2018
1080
0.190
 Why?
Cyclophosphamide
7
2011
217
0.190
 Why?
Orchiectomy
1
2021
57
0.190
 Why?
Rats
7
2022
4958
0.190
 Why?
Breast
4
2018
139
0.190
 Why?
Retroperitoneal Neoplasms
1
2021
22
0.190
 Why?
Survival Analysis
7
2005
1211
0.180
 Why?
Neoplasm Staging
8
2021
1167
0.180
 Why?
Neoplastic Stem Cells
2
2014
329
0.180
 Why?
Middle Aged
26
2021
26719
0.180
 Why?
Teratoma
1
2021
92
0.170
 Why?
TOR Serine-Threonine Kinases
3
2012
358
0.170
 Why?
Phosphatidylinositol 3-Kinases
3
2011
329
0.170
 Why?
Mice, SCID
1
2020
314
0.170
 Why?
Ovarian Neoplasms
4
1995
388
0.170
 Why?
Proto-Oncogene Proteins
5
2008
608
0.170
 Why?
Carcinoma, Papillary
1
1999
73
0.160
 Why?
Mitotic Index
1
1999
26
0.160
 Why?
Mice, Inbred NOD
1
2020
555
0.160
 Why?
Antigens, Neoplasm
2
2009
221
0.160
 Why?
Chemotherapy, Adjuvant
5
2015
332
0.160
 Why?
Receptors, Androgen
2
2017
131
0.160
 Why?
Autism Spectrum Disorder
1
2023
322
0.150
 Why?
Drug Synergism
3
2018
316
0.150
 Why?
Aromatase
1
2018
30
0.150
 Why?
Kaplan-Meier Estimate
1
2020
811
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
48
0.150
 Why?
HSP90 Heat-Shock Proteins
1
2018
43
0.150
 Why?
Phenylthiohydantoin
2
2017
40
0.150
 Why?
Ovariectomy
4
2022
116
0.150
 Why?
Down-Regulation
3
2010
594
0.150
 Why?
Fluorouracil
5
2009
152
0.150
 Why?
Tumor Burden
4
2022
259
0.150
 Why?
In Situ Hybridization, Fluorescence
4
2008
309
0.140
 Why?
Poly(ADP-ribose) Polymerases
2
2009
88
0.140
 Why?
Cell Division
4
2005
758
0.140
 Why?
Postmenopause
5
2022
303
0.140
 Why?
Estrogen Receptor alpha
2
2018
121
0.140
 Why?
Organic Cation Transport Proteins
1
2017
26
0.140
 Why?
Triazoles
1
2018
131
0.140
 Why?
Caspase 3
3
2006
235
0.140
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
226
0.130
 Why?
Smad Proteins
1
2016
39
0.130
 Why?
Gene Knock-In Techniques
1
2016
46
0.130
 Why?
Ovary
1
2017
191
0.130
 Why?
Calcitriol
1
2016
53
0.130
 Why?
Estrogens
1
2018
312
0.130
 Why?
Proteins
2
1992
908
0.130
 Why?
Mental Disorders
1
2023
892
0.120
 Why?
Drug Screening Assays, Antitumor
2
2016
180
0.120
 Why?
Protein Tyrosine Phosphatases
1
2016
147
0.120
 Why?
Gene Amplification
2
2009
95
0.120
 Why?
Fatty Acid Synthase, Type I
1
2014
5
0.120
 Why?
Disease Progression
6
2018
2380
0.120
 Why?
Immunoradiometric Assay
1
1994
2
0.120
 Why?
Mice, Knockout
1
2020
2565
0.120
 Why?
Cathepsin D
1
1994
14
0.120
 Why?
Antibodies, Monoclonal, Humanized
4
2013
663
0.120
 Why?
Postpartum Period
2
2014
278
0.110
 Why?
Immunoprecipitation
2
2011
151
0.110
 Why?
Tumor Cells, Cultured
5
2009
849
0.110
 Why?
Androgen Receptor Antagonists
1
2014
30
0.110
 Why?
Insulin-Like Growth Factor I
1
2016
286
0.110
 Why?
Adenocarcinoma
3
2012
795
0.110
 Why?
Androgen Antagonists
1
2014
69
0.110
 Why?
Receptor, ErbB-4
2
2010
18
0.110
 Why?
Transforming Growth Factor beta
1
2016
448
0.110
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
69
0.110
 Why?
Vitamin D
1
2016
341
0.100
 Why?
Disease Models, Animal
4
2017
3531
0.100
 Why?
Blotting, Western
3
2011
1147
0.100
 Why?
Overnutrition
1
2012
30
0.100
 Why?
Nucleic Acid Hybridization
2
2003
187
0.100
 Why?
RNA, Messenger
4
2016
2552
0.100
 Why?
Gene Expression Profiling
2
2016
1518
0.100
 Why?
Aminosalicylic Acids
1
2012
6
0.100
 Why?
DNA, Neoplasm
6
2005
157
0.100
 Why?
Benzenesulfonates
1
2012
20
0.100
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
213
0.100
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
49
0.100
 Why?
Chromones
1
2011
35
0.100
 Why?
Proportional Hazards Models
4
2005
1075
0.100
 Why?
Cohort Studies
2
2020
4894
0.100
 Why?
Genital Diseases, Female
1
1991
25
0.100
 Why?
Dasatinib
1
2011
46
0.090
 Why?
Fluoxymesterone
1
1991
2
0.090
 Why?
Mitosis
3
2001
164
0.090
 Why?
Apoptosis Regulatory Proteins
1
2012
171
0.090
 Why?
Thiazoles
1
2011
110
0.090
 Why?
S Phase
2
2010
69
0.090
 Why?
Weight Gain
3
2022
453
0.090
 Why?
Morpholines
1
2011
102
0.090
 Why?
Reagent Kits, Diagnostic
1
1991
42
0.090
 Why?
Neoplasm Metastasis
5
2005
522
0.090
 Why?
Genital Neoplasms, Female
1
1991
70
0.090
 Why?
Aged
12
2015
19061
0.090
 Why?
Chromosomes, Human, Pair 17
3
2002
56
0.090
 Why?
Proto-Oncogenes
1
1989
26
0.090
 Why?
Flow Cytometry
3
2007
1083
0.090
 Why?
Adult
15
2021
30528
0.090
 Why?
Antibiotics, Antineoplastic
2
2009
109
0.080
 Why?
Radioisotopes
1
1989
28
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
1842
0.080
 Why?
Anthracyclines
1
2009
41
0.080
 Why?
DNA Topoisomerases, Type II
1
2009
44
0.080
 Why?
Treatment Outcome
5
2007
9084
0.080
 Why?
DNA-Binding Proteins
2
2009
1314
0.080
 Why?
Pyrimidines
1
2011
376
0.080
 Why?
Epithelial Cells
1
2014
950
0.080
 Why?
Mutation
3
1995
3344
0.080
 Why?
Gene Deletion
2
2002
356
0.080
 Why?
MAP Kinase Signaling System
1
2010
276
0.080
 Why?
AMP-Activated Protein Kinases
1
2009
172
0.080
 Why?
RNA, Small Interfering
2
2007
535
0.070
 Why?
Mice, Nude
1
2009
630
0.070
 Why?
Energy Metabolism
1
2012
731
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
923
0.070
 Why?
Gene Dosage
1
2008
129
0.070
 Why?
Time Factors
4
2015
6112
0.070
 Why?
Transcription Factors
2
2008
1528
0.070
 Why?
Protein Structure, Tertiary
1
2009
796
0.070
 Why?
Immunoenzyme Techniques
3
1999
192
0.070
 Why?
Proto-Oncogene Proteins c-akt
3
2016
398
0.070
 Why?
Mitochondria
3
2008
747
0.070
 Why?
Enzyme Precursors
1
2006
15
0.070
 Why?
Epigenesis, Genetic
1
2010
520
0.070
 Why?
Receptor, Notch1
1
2006
59
0.060
 Why?
Multigene Family
2
2003
190
0.060
 Why?
Lamin Type B
1
2005
5
0.060
 Why?
Age Factors
3
2003
2894
0.060
 Why?
Tumor Microenvironment
2
2018
430
0.060
 Why?
Herpes Simplex
1
2006
87
0.060
 Why?
Herpesvirus 1, Human
1
2006
76
0.060
 Why?
Follow-Up Studies
4
2007
4411
0.060
 Why?
Cell Nucleolus
1
2005
17
0.060
 Why?
Nitriles
2
2017
149
0.060
 Why?
Aged, 80 and over
4
2000
6344
0.060
 Why?
Benzamides
2
2017
169
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
107
0.060
 Why?
Feedback
1
2005
144
0.060
 Why?
RNA Interference
3
2015
433
0.060
 Why?
Adipose Tissue
2
2018
539
0.060
 Why?
Predictive Value of Tests
4
2011
1796
0.060
 Why?
Protein Kinases
1
2006
307
0.060
 Why?
Rats, Wistar
2
2017
368
0.060
 Why?
Tacrolimus Binding Protein 1A
1
2003
7
0.060
 Why?
Tacrolimus Binding Proteins
1
2003
16
0.060
 Why?
Mice, Inbred Strains
1
2004
396
0.050
 Why?
Genes, Tumor Suppressor
1
2003
77
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
5
0.050
 Why?
Phytoestrogens
1
2003
13
0.050
 Why?
Plant Preparations
1
2003
23
0.050
 Why?
Estrogen Antagonists
1
2003
39
0.050
 Why?
Lymph Node Excision
2
2021
139
0.050
 Why?
Cell Line
2
2003
2635
0.050
 Why?
Actins
1
2005
381
0.050
 Why?
Anticarcinogenic Agents
1
2003
67
0.050
 Why?
Chromosome Banding
1
2002
21
0.050
 Why?
Mammary Glands, Animal
1
2003
117
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
30
0.050
 Why?
Rodentia
1
2022
44
0.050
 Why?
Transfection
3
2015
866
0.050
 Why?
3' Untranslated Regions
2
2014
129
0.050
 Why?
Nuclear Proteins
2
2000
591
0.050
 Why?
Trefoil Factor-1
2
1992
2
0.050
 Why?
alpha-Fetoproteins
1
2021
31
0.050
 Why?
Fallopian Tubes
2
1991
29
0.050
 Why?
In Situ Nick-End Labeling
1
2001
119
0.050
 Why?
Chorionic Gonadotropin
1
2021
78
0.050
 Why?
Sweden
1
2021
65
0.050
 Why?
RNA, Catalytic
1
2002
182
0.050
 Why?
Plasmids
1
2002
343
0.050
 Why?
RNA Stability
1
2021
90
0.040
 Why?
Neoplasm, Residual
1
2021
104
0.040
 Why?
Antigens, Nuclear
1
2000
19
0.040
 Why?
Breast Diseases
1
2000
20
0.040
 Why?
Reproducibility of Results
2
2021
2762
0.040
 Why?
Enhancer Elements, Genetic
1
2000
151
0.040
 Why?
Integrin beta3
2
2013
9
0.040
 Why?
Telomerase
1
2001
206
0.040
 Why?
Tumor Suppressor Proteins
2
1992
282
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
5
0.040
 Why?
Case-Control Studies
2
2023
3003
0.040
 Why?
DNA Glycosylases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
6
0.040
 Why?
Loss of Function Mutation
1
2018
36
0.040
 Why?
Retrospective Studies
4
2005
12542
0.040
 Why?
Antibodies
1
2000
371
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
41
0.040
 Why?
Trans-Activators
1
2000
367
0.040
 Why?
NF-kappa B
1
2002
638
0.040
 Why?
Half-Life
1
2018
141
0.040
 Why?
Codon
3
1993
86
0.040
 Why?
Stromal Cells
1
2018
96
0.040
 Why?
Hyaluronan Receptors
1
1998
90
0.040
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
172
0.040
 Why?
Gene Expression
3
2013
1421
0.040
 Why?
Organic Cation Transporter 2
1
2017
8
0.040
 Why?
Extracellular Matrix Proteins
1
1998
127
0.030
 Why?
Antigens, CD
2
2014
442
0.030
 Why?
DNA Repair
1
1998
184
0.030
 Why?
Steroids
1
2017
144
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
11
0.030
 Why?
Chromatography, Liquid
1
2017
347
0.030
 Why?
Survival Rate
3
1998
1644
0.030
 Why?
Oncogenes
1
2016
103
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
26
0.030
 Why?
RNA
1
2001
809
0.030
 Why?
Oncogene Proteins
1
1995
53
0.030
 Why?
Cell Nucleus
3
2006
554
0.030
 Why?
Homeodomain Proteins
1
2018
463
0.030
 Why?
Analysis of Variance
2
2014
1226
0.030
 Why?
Mammary Glands, Human
1
2014
60
0.030
 Why?
Tosyl Compounds
1
2014
14
0.030
 Why?
Mass Spectrometry
1
2017
633
0.030
 Why?
Integrin alpha6
1
2013
8
0.030
 Why?
Neoplasms
2
2012
2097
0.030
 Why?
Leukocyte Common Antigens
1
2014
75
0.030
 Why?
Testosterone
1
2017
343
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
53
0.030
 Why?
Brain Neoplasms
2
1993
979
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
270
0.030
 Why?
Sirolimus
2
2006
181
0.030
 Why?
Parity
1
2014
98
0.030
 Why?
Immunoassay
1
1994
95
0.030
 Why?
Premenopause
1
2014
106
0.030
 Why?
Anilides
1
2014
67
0.030
 Why?
Interleukin-6
1
2017
676
0.030
 Why?
Neovascularization, Pathologic
1
1995
281
0.030
 Why?
Transplantation, Heterologous
1
2014
181
0.030
 Why?
Neoplasm Transplantation
1
2014
228
0.030
 Why?
bcl-2-Associated X Protein
2
2007
45
0.030
 Why?
Organ Specificity
1
2013
268
0.030
 Why?
Lactation
1
2014
149
0.030
 Why?
Young Adult
2
2021
10455
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2013
42
0.030
 Why?
Immune System
1
2014
172
0.030
 Why?
Molecular Targeted Therapy
1
2015
347
0.030
 Why?
Lipogenesis
1
2012
56
0.030
 Why?
Point Mutation
1
1993
216
0.030
 Why?
Astrocytoma
1
1993
108
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Gene Knockdown Techniques
1
2013
299
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1139
0.020
 Why?
Peritoneum
1
1991
36
0.020
 Why?
Glycolysis
1
2012
226
0.020
 Why?
Pilot Projects
1
2015
1372
0.020
 Why?
Mucins
1
1991
61
0.020
 Why?
Pregnancy
2
2014
5517
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
50
0.020
 Why?
Blotting, Northern
1
2010
193
0.020
 Why?
Evaluation Studies as Topic
1
1991
167
0.020
 Why?
Hormones
1
1991
132
0.020
 Why?
Soft Tissue Neoplasms
1
1991
90
0.020
 Why?
Cells, Cultured
2
2013
3881
0.020
 Why?
In Situ Hybridization
1
2010
292
0.020
 Why?
Glioblastoma
1
1993
253
0.020
 Why?
Prospective Studies
1
2021
6217
0.020
 Why?
Precipitin Tests
1
1989
88
0.020
 Why?
Risk Factors
1
2003
8628
0.020
 Why?
Radionuclide Imaging
1
1989
115
0.020
 Why?
Odds Ratio
1
1992
953
0.020
 Why?
Protein Multimerization
1
2010
157
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
740
0.020
 Why?
Lymph Nodes
1
1991
419
0.020
 Why?
Drug Interactions
1
2009
338
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
55
0.020
 Why?
Male
3
2023
55554
0.020
 Why?
Cytochromes c
1
2007
63
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Biomarkers
1
2017
3408
0.020
 Why?
Aging
2
2002
1618
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
14
0.020
 Why?
Amino Acid Sequence
3
1998
1982
0.020
 Why?
Caspase 8
1
2006
43
0.020
 Why?
Caspase 9
1
2006
48
0.020
 Why?
Cysteine Endopeptidases
1
2006
60
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
13
0.020
 Why?
Caspase 7
1
2006
20
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
27
0.020
 Why?
Isoenzymes
1
2007
283
0.020
 Why?
Antineoplastic Agents, Phytogenic
1
2007
181
0.020
 Why?
Vero Cells
1
2006
63
0.020
 Why?
Cytosol
1
2006
208
0.020
 Why?
Promoter Regions, Genetic
1
2010
1131
0.020
 Why?
Virus Assembly
1
2006
67
0.020
 Why?
Base Sequence
2
2003
2114
0.020
 Why?
Adolescent
2
2021
17831
0.020
 Why?
Protein Binding
1
2010
1889
0.010
 Why?
Taxoids
1
2004
93
0.010
 Why?
Protein Processing, Post-Translational
1
2006
399
0.010
 Why?
Mice, Inbred C57BL
2
2003
4689
0.010
 Why?
DNA, Complementary
1
2003
256
0.010
 Why?
Melanoma, Experimental
1
2003
89
0.010
 Why?
Cell Adhesion
1
2003
431
0.010
 Why?
Exons
2
1993
302
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
39
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
57
0.010
 Why?
Gene Targeting
1
2002
75
0.010
 Why?
Templates, Genetic
1
2001
59
0.010
 Why?
Substrate Specificity
1
2002
352
0.010
 Why?
Molecular Sequence Data
2
1998
2785
0.010
 Why?
DNA, Superhelical
1
2000
11
0.010
 Why?
DNA Footprinting
1
2000
28
0.010
 Why?
Mice, Inbred BALB C
1
2003
1143
0.010
 Why?
Proto-Oncogene Proteins c-ets
1
2000
51
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
17
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
104
0.010
 Why?
Macromolecular Substances
1
2000
200
0.010
 Why?
Pathology, Clinical
1
2000
32
0.010
 Why?
Gene Silencing
1
2000
171
0.010
 Why?
Multicenter Studies as Topic
1
2000
248
0.010
 Why?
Forecasting
1
2000
330
0.010
 Why?
Genetic Therapy
1
2000
257
0.010
 Why?
Receptors, Cell Surface
1
2000
355
0.010
 Why?
Binding Sites
1
2000
1168
0.010
 Why?
Nucleic Acid Conformation
1
2000
669
0.010
 Why?
ras Proteins
1
1998
138
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
16
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
49
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
58
0.010
 Why?
Adenine
1
1998
219
0.010
 Why?
Societies, Medical
1
2000
663
0.010
 Why?
Immunoblotting
1
1997
283
0.010
 Why?
Hyaluronic Acid
1
1998
188
0.010
 Why?
United States
2
2004
12176
0.010
 Why?
Heterozygote
1
1996
251
0.010
 Why?
Melanoma
1
2002
619
0.010
 Why?
Protein Isoforms
1
1997
338
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
25
0.010
 Why?
Factor VIII
1
1995
53
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1214
0.010
 Why?
Cyclin D1
1
1995
61
0.010
 Why?
Transcription, Genetic
1
2000
1313
0.010
 Why?
Single-Blind Method
1
1995
258
0.010
 Why?
Observer Variation
1
1995
295
0.010
 Why?
Alleles
1
1996
789
0.010
 Why?
Biopsy
1
1995
1036
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
49
0.010
 Why?
Risk Assessment
1
2000
2967
0.010
 Why?
Peripheral Nerves
1
1991
64
0.010
 Why?
DNA
1
1996
1352
0.010
 Why?
Protein Conformation
1
1993
805
0.010
 Why?
Polymorphism, Genetic
1
1993
610
0.010
 Why?
Lung Neoplasms
1
2002
2177
0.010
 Why?
Cerebral Cortex
1
1991
380
0.000
 Why?
Glioma
1
1991
294
0.000
 Why?
Child
1
1993
18404
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (434) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)